Myron Chu
Impact in
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
-
- T-cell and B-cell Immunology
- Atherosclerosis and Cardiovascular Diseases
- Immune Cell Function and Interaction
Papers in
- Rheumatology 13
- Systemic Lupus Erythematosus Research 9
- Rheumatoid Arthritis Research and Therapies 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Damon Bass (7 shared papers)David A. Roth (8 shared papers)Yoshiya Tanaka (5 shared papers)Sang‐Cheol Bae (3 shared papers)Fengchun Zhang (4 shared papers)Jie Zheng (3 shared papers)David Gordon (1 shared paper)Regina Kurrasch (7 shared papers)
- Journals
- Modern Rheumatology (3 papers)Arthritis Research & Therapy (2 papers)RMD Open (2 papers)Annals of the Rheumatic Diseases (2 papers)Arthritis Care & Research (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Myron Chu
14 papers receiving 398 citations
Myron Chu's Hit Papers
Peers
Comparison fields: 5 of 34
- Rheumatology 302
- Immunology 129
- Radiology, Nuclear Medicine and Imaging 107
- Pathology and Forensic Medicine 33
- Nephrology 13
Countries citing papers authored by Myron Chu
This map shows the geographic impact of Myron Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myron Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myron Chu more than expected).
Fields of papers citing papers by Myron Chu
This network shows the impact of papers produced by Myron Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myron Chu. The network helps show where Myron Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Myron Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea Hit paper breakdown → | 2018 | 230 |
| 2 | 2015 | 42 | |
| 3 | 2013 | 34 | |
| 4 | 2021 | 18 | |
| 5 | 2016 | 18 | |
| 6 | 2018 | 14 | |
| 7 | 2022 | 12 | |
| 8 | 2019 | 12 | |
| 9 | 2022 | 8 | |
| 10 | 2024 | 7 | |
| 11 | 2022 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2025 | 1 |
About Myron Chu
Myron Chu is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging, Immunology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 14 papers that have together received 405 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (9 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Celiac Disease Research and Management (1 paper), Atherosclerosis and Cardiovascular Diseases (1 paper), Diabetes and associated disorders (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and Adrenal Hormones and Disorders (1 paper). The work is most often cited by research in Rheumatology (302 citations), Immunology (129 citations), Radiology, Nuclear Medicine and Imaging (107 citations), Pathology and Forensic Medicine (33 citations) and Nephrology (13 citations). Myron Chu has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Damon Bass, David A. Roth, Yoshiya Tanaka, Sang‐Cheol Bae, Fengchun Zhang, Jie Zheng, David Gordon, Regina Kurrasch, David J. Chang and Emilia Quattrocchi. Their work appears in journals such as Modern Rheumatology, Arthritis Research & Therapy, RMD Open, Annals of the Rheumatic Diseases and Arthritis Care & Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.